Over 12.4 mn unutilised Covid vaccine doses still with states: Centre

Over 94,66,420 doses are in the pipeline and will be received by them within the next three days, the Union Health Ministry said on Thursday.

covaxin, bharat biotech, coronavirus vaccine, covid-19, vaccination
Press Trust of India New Delhi
1 min read Last Updated : Jul 01 2021 | 6:48 PM IST

More than 1.24 crore balance and unutilised COVID-19 vaccine doses are still available with the states and UTs and over 94,66,420 doses are in the pipeline and will be received by them within the next three days, the Union Health Ministry said on Thursday.

Over 32.92 crore vaccine doses have been provided to states and UTs so far through Government of India (free of cost channel) and direct state procurement category.

Of this, the total consumption, including wastage is 31,67,50,891 doses, the ministry said.

"More than 1.24 crore (1,24,50,909) balance and unutilised Covid vaccine doses are still available with the states and UTs to be administered.

"Furthermore, more than 94,66,420 vaccine doses are in the pipeline and will be received by the states and UTs within the next 3 days," the ministry said.

The Centre is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country.

The new phase of universalisation of COVID-19 vaccination commenced from 21st June 2021.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jul 01 2021 | 6:48 PM IST

Next Story